Effectiveness of multi-disciplinary team management on 5-year overall survival for patients with stage III lung cancer.
Camilla ValsecchiAndrea FranzaGiorgio BoganiLuigi RolliMichele FerrariGiovanni LeuzziAlessia StanziFederica SabiaUgo PastorinoArsela PrelajPublished in: Journal of thoracic disease (2024)
The implementation of an MDT increased the 5-year OS in both resected and non-resected stage III LC patients. Implementing MDT might be useful in improving the management of therapy with less invasive local and surgical strategies personalized for each LC patient.
Keyphrases
- prognostic factors
- quality improvement
- end stage renal disease
- lymph node
- randomized controlled trial
- ejection fraction
- newly diagnosed
- healthcare
- primary care
- systematic review
- simultaneous determination
- mass spectrometry
- palliative care
- case report
- patient reported outcomes
- tandem mass spectrometry
- solid phase extraction